TABLE OF CONTENTS
1 INTRODUCTION 9
1.1 OBJECTIVES OF THE STUDY 9
1.2 MARKET DEFINITION 9
1.3 OVERVIEW OF CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET 9
1.4 CURRENCY AND PRICING 10
1.5 LIMITATION 11
1.6 MARKETS COVERED 11
2 MARKET SEGMENTATION 12
2.1 MARKETS COVERED 12
2.2 YEARS CONSIDERED FOR THE STUDY 13
2.3 CURRENCY AND PRICING 13
2.4 RESEARCH METHODOLOGY 14
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 17
2.6 DBMR MARKET CHALLENGE MATRIX 18
2.7 MARKET APPLICATION COVERAGE GRID 19
2.8 DBMR VENDOR SHARE ANALYSIS 20
2.9 SECONDARY SOURCES 21
2.10 ASSUMPTIONS 21
3 MARKET OVERVIEW 22
3.1 DRIVERS 24
3.1.1 RISING NUMBER OF CHRONIC DISEASES 24
3.1.2 RISING AGING POPULATION 24
3.1.3 GROWING NUMBER OF DIAGNOSTIC CENTERS 25
3.1.4 INCREASE IN THE RESEARCH AND DEVELOPMENTAL ACTIVITIES OF CONTRAST AGENTS 26
3.2 RESTRAINTS 28
3.2.1 SIDE EFFECTS ASSOCIATED WITH CONTRAST AGENTS. 28
3.3 OPPORTUNITIES 28
3.3.1 RISING HEALTHCARE EXPENDITURE 28
3.3.2 INCREASE IN NUMBER OF PUBLIC AND PRIVATE HOSPITALS 30
3.4 CHALLENGES 31
3.4.1 LACK OF AWARENESS REGARDING THE PROPER DOSAGE OF CONTRAST AGENT 31
?
4 EXECUTIVE SUMMARY 32
5 PREMIUM INSIGHTS 34
6 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE 36
6.1 OVERVIEW 37
6.2 IODINATED CONTRAST MEDIA 38
6.3 BARIUM-BASED CONTRAST MEDIA 38
6.4 MICROBUBBLE CONTRAST MEDIA 38
6.5 GOLD NANOPARTICLE CONTRAST AGENTS 38
6.6 OTHERS 38
7 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION 39
7.1 OVERVIEW 40
7.2 CARDIOLOGY 42
7.2.1 PERCUTANEOUS CORONARY INTERVENTION 42
7.2.2 STRUCTURAL HEART DISEASE 42
7.2.3 CONGENITAL HEART DISEASE 42
7.2.4 ELECTROPHYSIOLOGY 42
7.3 GASTROENTEROLOGY 42
7.4 NEUROLOGY 43
7.5 ONCOLOGY 43
7.6 UROLOGY 43
7.7 GENERAL SURGERY 43
8 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER 44
8.1 OVERVIEW 45
8.2 IMAGING CENTERS 46
8.3 HOSPITAL 46
8.4 CLINICS 46
8.5 DIAGNOSTIC CENTER 46
8.6 AMBULATORY SURGICAL CENTERS 46
8.7 PRIVATE PRACTICES 46
?
9 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, COMPANY LANDSCAPE 47
9.1 COMPANY SHARE ANALYSIS; CANADA 47
10 COMPANY PROFILES 48
10.1 GENERAL ELECTRIC COMPANY 48
10.1.1 COMPANY SNAPSHOT 48
10.1.2 REVENEUE ANALYSIS 48
10.1.3 PRODUCT PORTFOLIO 49
10.1.4 RECENT DEVELOPMENTS 49
10.2 BRACCO 50
10.2.1 COMPANY SNAPSHOT 50
10.2.2 GEOGRAPHICAL PRESENCE 50
10.2.3 PRODUCT PORTFOLIO 51
10.2.4 RECENT DEVELOPMENTS 52
10.3 LANTHEUS MEDICAL IMAGING, INC. 53
10.3.1 COMPANY SNAPSHOT 53
10.3.2 REVENUE ANALYSIS 53
10.3.3 PRODUCT PORTFOLIO 54
10.3.4 RECENT DEVELOPMENTS 54
10.4 GUERBET 55
10.4.1 COMPANY SNAPSHOT 55
10.4.2 REVENEUE ANALYSIS 55
10.4.3 PRODUCT PORTFOLIO 56
10.4.4 RECENT DEVELOPMENTS 56
10.5 57
10.6 FUJIFILM VISUALSONICS INC. 57
10.6.1 COMPANY SNAPSHOT 57
10.6.2 GEOGRAPHICAL PRESENCE 57
10.6.3 PRODUCT PORTFOLIO 58
10.6.4 RECENT DEVELOPMENT 58
11 RELATED REPORTS 59
12 QUESTIONNAIRE 63